\begin{table}[H]
\centering
\resizebox{\linewidth}{!}{
\begin{tabular}[t]{lrlrlr}
\toprule
\multicolumn{2}{c}{PBS} & \multicolumn{2}{c}{XP-EHH} & \multicolumn{2}{c}{iHS} \\
\cmidrule(l{3pt}r{3pt}){1-2} \cmidrule(l{3pt}r{3pt}){3-4} \cmidrule(l{3pt}r{3pt}){5-6}
Fenótipo & N & Fenótipo & N & Fenótipo & N\\
\midrule
\cellcolor{gray!6}{Body Mass Index} & \cellcolor{gray!6}{6} & \cellcolor{gray!6}{Body Mass Index} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Asthma} & \cellcolor{gray!6}{2}\\
Crohn's disease & 5 & Body Weight & 2 & 3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2 DEFICIENCY & 1\\
\cellcolor{gray!6}{Inflammatory bowel disease} & \cellcolor{gray!6}{5} & \cellcolor{gray!6}{Chronotype} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY} & \cellcolor{gray!6}{1}\\
Alcohol consumption (max-drinks) & 4 & INSULIN & 2 & 3-hydroxy-3-methylglutaryl-CoA synthase deficiency & 1\\
\cellcolor{gray!6}{Alcohol dependence symptom count} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Alopecia areata} & \cellcolor{gray!6}{1}\\
Coffee consumption & 4 & Albumins & 1 & Asthma (childhood onset) & 1\\
\cellcolor{gray!6}{Diastolic blood pressure x alcohol consumption interaction (2df test)} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{Amyotrophic lateral sclerosis (sporadic)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Atopic dermatitis} & \cellcolor{gray!6}{1}\\
Mean arterial pressure x alcohol consumption interaction (2df test) & 4 & Anophthalmia - microphthalmia & 1 & Autism spectrum disorder or schizophrenia & 1\\
\cellcolor{gray!6}{Myocardial infarction} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{Anorexia nervosa} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Blood protein levels} & \cellcolor{gray!6}{1}\\
Response to alcohol consumption (flushing response) & 4 & Arterial stiffness index & 1 & Body Weight Changes & 1\\
\cellcolor{gray!6}{Serum uric acid levels} & \cellcolor{gray!6}{4} & \cellcolor{gray!6}{Autosomal dominant non-syndromic intellectual disability} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Breast size} & \cellcolor{gray!6}{1}\\
Systolic blood pressure x alcohol consumption interaction (2df test) & 4 & Autosomal dominant non-syndromic sensorineural deafness type DFNA & 1 & Change in glucose in response to thiazide diuretic treatment in hypertension & 1\\
\cellcolor{gray!6}{Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)} & \cellcolor{gray!6}{3} & \cellcolor{gray!6}{Autosomal dominant nonsyndromic deafness 2A} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)} & \cellcolor{gray!6}{1}\\
Estimated glomerular filtration rate & 3 & Bitter non-alcoholic beverage consumption & 1 & Crohn's disease & 1\\
\cellcolor{gray!6}{Hematological and biochemical traits} & \cellcolor{gray!6}{3} & \cellcolor{gray!6}{Blood metabolite levels} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Cutaneous psoriasis} & \cellcolor{gray!6}{1}\\
Urate levels & 3 & Blood pressure & 1 & Diastolic blood pressure & 1\\
\cellcolor{gray!6}{Alcohol dependence} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Body Height} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Diastolic blood pressure x alcohol consumption interaction (2df test)} & \cellcolor{gray!6}{1}\\
Coronary Artery Disease & 2 & Bone mineral density (total hip) & 1 & Ewing sarcoma & 1\\
\cellcolor{gray!6}{Diastolic blood pressure} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{FETAL AKINESIA DEFORMATION SEQUENCE} & \cellcolor{gray!6}{1}\\
Drinking behavior & 2 & Cholesterol, HDL & 1 & Familial infantile myasthenia & 1\\
\cellcolor{gray!6}{Educational attainment} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Corneal structure} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Inflammatory bowel disease} & \cellcolor{gray!6}{1}\\
Esophageal Cancer & 2 & Craniosynostosis-microretrognathia-severe intellectual disability syndrome & 1 & MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC & 1\\
\cellcolor{gray!6}{Gout combined type} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{DEAFNESS, AUTOSOMAL DOMINANT 2A} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Malignant tumor of prostate} & \cellcolor{gray!6}{1}\\
HDL cholesterol levels & 2 & Daytime sleep phenotypes & 1 & Metabolite levels & 1\\
\cellcolor{gray!6}{Hypothyroidism} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Diabetes Mellitus} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY} & \cellcolor{gray!6}{1}\\
Mean arterial pressure & 2 & Diastolic blood pressure & 1 & Presynaptic congenital myasthenic syndromes & 1\\
\cellcolor{gray!6}{Metabolic syndrome} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{Diisocyanate-induced asthma} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Schizophrenia} & \cellcolor{gray!6}{1}\\
Platelet Count & 2 & EHMT1-LIKE INTELLECTUAL DISABILITY & 1 & Selective IgA deficiency & 1\\
\cellcolor{gray!6}{Plateletcrit} & \cellcolor{gray!6}{2} & \cellcolor{gray!6}{EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1} & \cellcolor{gray!6}{1} & \cellcolor{gray!6}{Systemic lupus erythematosus} & \cellcolor{gray!6}{1}\\
Psoriasis & 2 & Echocardiography & 1 & Systolic blood pressure & 1\\
\bottomrule
\end{tabular}}
\end{table}
